GleamWall
中文EN

LQDA Liquidia Corp

Pharmaceutical Preparations · Nasdaq · SEC CIK 1819576 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY2,233.6%
TTM net income YoY192.7%
TTM EPS YoY178.2%
Revenue 3-yr CAGR193.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin37.4%
Net margin30.7%
FCF margin33.4%
EBITDA margin37.7%

Returns

ROE131.8%
ROA35.6%
ROIC (approx.)—
Asset turnover1.16x

Leverage & solvency

Liabilities / assets62.6%
Debt / equity0.00x
Current ratio2.31x
Interest coverage6.33x

Cash quality & payout

Operating cash flow / net income1.21x
Accruals ratio-7.5%
Payout ratio—
Capex / revenue3.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$225.30M$171.68M$132.87M$92.02M$54.34M$8.84M$3.12M$2.92M
Cost of revenue——————$1.52M$1.35M
Gross profit——————$1.60M$1.56M
R&D expense$25.27M$17.18M$12.57M$16.94M$9.35M$6.02M$6.97M$16.48M
SG&A expense$59.02M$57.43M$46.94M$48.24M$40.06M$38.82M$30.06M$21.20M
Operating income-$263.52M$85.52M$61.50M$19.79M$1.77M-$37.51M-$35.42M-$36.11M
Interest expense—$6.30M$6.49M$6.90M$6.95M$5.66M$4.67M$4.51M
Pretax income-$266.40M$81.70M$56.78M—-$3.53M-$41.58M-$38.37M—
Income tax-$30.07M$6.97M$3.92M$0$0$0$0—
Net income-$236.33M$74.72M$52.86M$14.55M-$3.53M-$41.58M-$38.37M-$38.51M
EBITDA-$263.32M$85.82M$62.00M$20.11M$2.07M-$37.30M-$34.97M-$35.59M
EPS (basic)-2.640.840.60—-0.04-0.49-0.45—
EPS (diluted)-2.640.740.52—-0.04-0.49-0.45—
Weighted avg. shares (diluted)89.52M101.40M101.11M—86.33M85.59M85.17M—
Balance sheet
Cash & equivalents$396.09M$284.18M$222.79M$190.68M$157.50M$173.42M$169.76M$176.48M
Receivables$106.75M$108.58M$74.16M$54.09M$35.96M$9.97M$1.25M$2.72M
Inventory$36.17M$36.18M$28.51M$23.80M$24.53M$6.44M$1.35M$241,000
Current assets$596.72M$437.71M$333.06M$273.40M$226.72M$195.58M$177.21M$185.10M
PP&E, net$44.51M$34.55M$20.84M$11.84M$10.70M$9.54M$8.48M$8.30M
Goodwill$3.90M$3.90M$3.90M$3.90M$3.90M$3.90M$3.90M$3.90M
Intangibles—$2.85M$2.89M$2.95M$2.99M$3.05M$3.11M$3.16M
Total assets$682.94M$521.92M$401.53M$327.93M$275.98M$257.41M$227.43M$230.31M
Current liabilities$585.40M$189.30M$149.74M$135.77M$102.94M$78.41M$60.52M$41.78M
Total liabilities$708.38M$326.80M$292.95M$283.19M$253.93M$242.22M$177.72M$150.94M
Shareholders' equity-$25.43M$195.11M$108.58M$44.75M$22.05M$15.19M$49.71M$79.38M
Shares outstanding89.73M89.10M88.31M87.20M86.82M85.86M85.30M84.68M
Cash flow statement
Operating cash flow$146.68M$80.24M$52.99M$44.24M-$9.77M-$39.48M-$30.68M-$20.81M
Capital expenditure$16.90M$11.23M$2.83M$2.04M$911,000$1.06M$330,000$1.29M
Free cash flow$129.78M$69.01M$50.16M$42.21M-$10.68M-$40.54M-$31.01M-$22.10M
Investing cash flow-$16.90M-$12.23M-$2.83M-$4.04M-$911,000-$1.06M-$330,000-$4.78M
Financing cash flow-$17.87M-$6.61M-$18.05M-$7.02M-$5.25M$47.71M$24.29M-$2.30M
Depreciation & amortization$200,000$300,000$497,000$320,000$300,000$200,000$451,000$518,000
Stock-based compensation$13.68M$10.37M$9.22M$7.21M$7.90M$6.93M$7.44M$5.03M

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.